Clinical Trial Update: A Multicentre, Randomized, Double-blind, Allopurinol Controlled Study to Evaluate the Efficacy and Safety of SHR4640 in Subjects With Gout [Phase 3]

View source ↗

Summary

A Phase 3 multicenter, randomized, double-blind trial evaluating the efficacy and safety of SHR4640 in gout with allopurinol as a comparator; the study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• SHR4640

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Gout | Phase 3 | Status: COMPLETED